Emerging Graphene Technology Company

Hydrothermal Graphite Deposit Ammenable for Commercial Graphene Applications

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Ringer

Rank: President [?]

Points: 16773 [?]

Votes: 73 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Greg Fenton on how ZEN Graphene’s disease detection technology will “revolutionize the way testing is done”

posted on Jun 18, 2021 05:27PM

https://investorintel.com/investorintel-video/greg-fenton-on-how-zen-graphenes-disease-detection-technology-will-revolutionize-the-way-testing-is-done/

https://www.youtube.com/watch?v=Pav8eju4k84

Greg Fenton on how ZEN Graphene’s disease detection technology will “revolutionize the way testing is done”

In a recent InvestorIntel interview, Tracy Weslosky speaks with Greg Fenton, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: ZEN) about ZEN’s exclusive worldwide rights to commercialize rapid, saliva-based COVID-19 antigen testing technology announced yesterday

In this InvestorIntel interview, which may also be viewed on YouTube (click here to subscribe to the InvestorIntel Channel), Greg went on to say that this saliva-based test is exceptionally accurate, similar to current PCR tests, and will “revolutionize the way testing is done”. Affordable, easy to use, scalable and provides results in under 10 minutes, Greg comments that this technology has the ability “to allow economies to reopen.” Tracy then asks the critical question with “will you be able to test for anything?”